Literature DB >> 23946610

Bone metastasis from early gastric cancer following non-curative endoscopic submucosal dissection.

Hiroyuki Kawabata1, Ichiro Oda, Haruhisa Suzuki, Satoru Nonaka, Shigetaka Yoshinaga, Hitoshi Katai, Hirokazu Taniguchi, Ryoji Kushima, Yutaka Saito.   

Abstract

A 67-year-old male underwent endoscopic submucosal dissection (ESD) to treat early gastric cancer (EGC) in 2001. The lesion (50 mm × 25 mm diameter) was histologically diagnosed as poorly differentiated adenocarcinoma, with an ulcer finding. Although the tumor was confined to the mucosa with no evidence of lymphovascular involvement, the ESD was regarded as a non-curative resection due to the histological type, tumor size, and existence of an ulcer finding (as indicated by the 2010 Japanese gastric cancer treatment guidelines, ver. 3). Despite strong recommendation for subsequent gastrectomy, the patient refused surgery. An alternative follow-up routine was designed, which included five years of biannual clinical examinations to detect and measure serum tumor markers and perform visual assessment of recurrence by endoscopy and computed tomography scan after which the examinations were performed annually. The patient's condition remained stable for eight years, until a complaint of back pain in 2010 prompted further clinical investigation. Bone scintigraphy indicated increased uptake. Histological examination of biopsy specimens taken from the lumbar spine revealed adenocarcinoma resembling the carcinoma cells from the EGC that had been treated previously by ESD, and which was consistent with immunohistochemical findings of gastrointestinal tract cancer. Thus, the diagnosis of bone metastasis from EGC was made. The reported rates of EGC recurrence in surgically resected cases range 1.4%-3.4%, but among these bone metastasis is very rare. To our knowledge, this is the first reported case of bone metastasis from EGC following a non-curative ESD and occurring after an eight-year disease-free interval.

Entities:  

Keywords:  Bone metastasis; Early gastric cancer; Endoscopic submucosal dissection; Late recurrence; Non-curative resection

Mesh:

Substances:

Year:  2013        PMID: 23946610      PMCID: PMC3740435          DOI: 10.3748/wjg.v19.i30.5016

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  16 in total

1.  Clinicopathological analysis for recurrence of early gastric cancer.

Authors:  Hyuk-Joon Lee; Yoon Ho Kim; Woo Ho Kim; Kuhn Uk Lee; Kuk Jin Choe; Jin-Pok Kim; Han-Kwang Yang
Journal:  Jpn J Clin Oncol       Date:  2003-05       Impact factor: 3.019

2.  Japanese gastric cancer treatment guidelines 2010 (ver. 3).

Authors: 
Journal:  Gastric Cancer       Date:  2011-06       Impact factor: 7.370

3.  Endoscopic mucosal resection for treatment of early gastric cancer.

Authors:  H Ono; H Kondo; T Gotoda; K Shirao; H Yamaguchi; D Saito; K Hosokawa; T Shimoda; S Yoshida
Journal:  Gut       Date:  2001-02       Impact factor: 23.059

4.  Causes of death and recurrence after surgery for early gastric cancer.

Authors:  S Guadagni; M Catarci; T Kinoshitá; M Valenti; G De Bernardinis; M Carboni
Journal:  World J Surg       Date:  1997-05       Impact factor: 3.352

5.  Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers.

Authors:  Takuji Gotoda; Akio Yanagisawa; Mitsuru Sasako; Hiroyuki Ono; Yukihiro Nakanishi; Tadakazu Shimoda; Yo Kato
Journal:  Gastric Cancer       Date:  2000-12       Impact factor: 7.370

6.  A case of bone marrow recurrence from gastric carcinoma after a nine-year disease-free interval.

Authors:  N Noda; T Sano; K Shirao; H Ono; H Katai; M Sasako; K Maruyama
Journal:  Jpn J Clin Oncol       Date:  1996-12       Impact factor: 3.019

7.  A multicenter retrospective study of endoscopic resection for early gastric cancer.

Authors:  Ichiro Oda; Daizo Saito; Masahiro Tada; Hiroyasu Iishi; Satoshi Tanabe; Tsuneo Oyama; Toshihiko Doi; Yoshihide Otani; Junko Fujisaki; Yoichi Ajioka; Tsutomu Hamada; Haruhiro Inoue; Takuji Gotoda; Shigeaki Yoshida
Journal:  Gastric Cancer       Date:  2006-11-24       Impact factor: 7.370

8.  Incidence of lymph node metastasis and the feasibility of endoscopic resection for undifferentiated-type early gastric cancer.

Authors:  Toshiaki Hirasawa; Takuji Gotoda; Satoshi Miyata; You Kato; Tadakazu Shimoda; Hirokazu Taniguchi; Junko Fujisaki; Takeshi Sano; Toshiharu Yamaguchi
Journal:  Gastric Cancer       Date:  2009-11-05       Impact factor: 7.370

9.  Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression.

Authors:  L Holmgren; M S O'Reilly; J Folkman
Journal:  Nat Med       Date:  1995-02       Impact factor: 53.440

10.  Is endoscopic submucosal dissection an effective treatment for operable patients with clinical submucosal invasive early gastric cancer?

Authors:  H Suzuki; I Oda; S Nonaka; S Yoshinaga; Y Saito
Journal:  Endoscopy       Date:  2013-01-10       Impact factor: 10.093

View more
  2 in total

1.  Risk factors for lymph node metastasis and long-term outcomes of patients with early gastric cancer after non-curative endoscopic submucosal dissection.

Authors:  Noboru Kawata; Naomi Kakushima; Kohei Takizawa; Masaki Tanaka; Rie Makuuchi; Masanori Tokunaga; Yutaka Tanizawa; Etsuro Bando; Taiichi Kawamura; Takashi Sugino; Kimihide Kusafuka; Tadakazu Shimoda; Takashi Nakajima; Masanori Terashima; Hiroyuki Ono
Journal:  Surg Endosc       Date:  2016-08-05       Impact factor: 4.584

2.  Is radical surgery necessary in all patients who do not meet the curative criteria for endoscopic submucosal dissection in early gastric cancer? A multi-center retrospective study in Japan.

Authors:  Waku Hatta; Takuji Gotoda; Tsuneo Oyama; Noboru Kawata; Akiko Takahashi; Yoshikazu Yoshifuku; Shu Hoteya; Koki Nakamura; Masaaki Hirano; Mitsuru Esaki; Mitsuru Matsuda; Ken Ohnita; Ryo Shimoda; Motoyuki Yoshida; Osamu Dohi; Jun Takada; Keiko Tanaka; Shinya Yamada; Tsuyotoshi Tsuji; Hirotaka Ito; Yoshiaki Hayashi; Tomohiro Nakamura; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2016-04-20       Impact factor: 7.527

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.